GlobeNewswire Inc.··Telix Pharmaceuticals LimitedTelix Pharmaceuticals to Showcase Next-Gen PSMA Cancer Therapy Portfolio
Telix Pharmaceuticals hosts webinar April 30 discussing next-gen PSMA cancer therapy pipeline, featuring OPTIMAL-PSMA2 trial data on TLX597-Tx candidate.
TLXclinical trialprostate cancer